Novel triazolo-pyrrolopyridines as inhibitors of Janus kinase 1-Reference-Cited by-同舟云学术

Novel triazolo-pyrrolopyridines as inhibitors of Janus kinase 1

Published:2013-06 Issue:12 Volume:23 Page:3592-3598
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Hurley Christopher A.,Blair Wade S.,Bull Richard J.,Chang Christine,Crackett Peter H.,Deshmukh Gauri,Dyke Hazel J.,Fong Rina,Ghilardi Nico,Gibbons Paul,Hewitt Peter R.,Johnson Adam,Johnson Tony,Kenny Jane R.,Kohli Pawan Bir,Kulagowski Janusz J.,Liimatta Marya,Lupardus Patrick J.,Maxey Robert J.,Mendonca Rohan,Narukulla Raman,Pulk Rebecca,Ubhayakar Savita,van Abbema Anne,Ward Stuart I.,Waszkowycz Bohdan,Zak Mark

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference36 articles.

1. Jak and Syk: Emerging their relevance to the treatment of inflammatory diseases

2. A new modality for immunosuppression: targeting the JAK/STAT pathway

3. Targeting JAK/STAT Signaling Pathway in Inflammatory Diseases

4. Selectivity and therapeutic inhibition of kinases: to be or not to be?

5. Signaling through the JAK/STAT pathway, recent advances and future challenges

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Calculation of binding affinity of JAK1 inhibitors via accurately computational estimation;Journal of Biomolecular Structure and Dynamics;2022-09-07

2. Identification of Potent and Selective JAK1 Lead Compounds Through Ligand-Based Drug Design Approaches;Frontiers in Pharmacology;2022-04-21

3. Design and Synthesis of New JAK1 Inhibitors based on Sulfonamide- Triazine Conjugates;Current Computer-Aided Drug Design;2021-12

4. Pharmacophore modeling of JAK1: A target infested with activity-cliffs;Journal of Molecular Graphics and Modelling;2020-09

5. An Update on JAK Inhibitors;Current Medicinal Chemistry;2019-06-20